1. Home
  2. TLSA vs CLSD Comparison

TLSA vs CLSD Comparison

Compare TLSA & CLSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLSA
  • CLSD
  • Stock Information
  • Founded
  • TLSA 2013
  • CLSD 2011
  • Country
  • TLSA United Kingdom
  • CLSD United States
  • Employees
  • TLSA N/A
  • CLSD N/A
  • Industry
  • TLSA Biotechnology: Pharmaceutical Preparations
  • CLSD Biotechnology: Pharmaceutical Preparations
  • Sector
  • TLSA Health Care
  • CLSD Health Care
  • Exchange
  • TLSA Nasdaq
  • CLSD Nasdaq
  • Market Cap
  • TLSA 87.8M
  • CLSD 74.3M
  • IPO Year
  • TLSA 2000
  • CLSD 2016
  • Fundamental
  • Price
  • TLSA $0.74
  • CLSD $0.93
  • Analyst Decision
  • TLSA
  • CLSD Strong Buy
  • Analyst Count
  • TLSA 0
  • CLSD 6
  • Target Price
  • TLSA N/A
  • CLSD $5.33
  • AVG Volume (30 Days)
  • TLSA 442.0K
  • CLSD 301.0K
  • Earning Date
  • TLSA 01-28-2025
  • CLSD 03-11-2025
  • Dividend Yield
  • TLSA N/A
  • CLSD N/A
  • EPS Growth
  • TLSA N/A
  • CLSD N/A
  • EPS
  • TLSA N/A
  • CLSD N/A
  • Revenue
  • TLSA N/A
  • CLSD $7,703,000.00
  • Revenue This Year
  • TLSA N/A
  • CLSD N/A
  • Revenue Next Year
  • TLSA N/A
  • CLSD $91.87
  • P/E Ratio
  • TLSA N/A
  • CLSD N/A
  • Revenue Growth
  • TLSA N/A
  • CLSD 248.39
  • 52 Week Low
  • TLSA $0.41
  • CLSD $0.80
  • 52 Week High
  • TLSA $1.74
  • CLSD $2.12
  • Technical
  • Relative Strength Index (RSI)
  • TLSA 44.91
  • CLSD 42.76
  • Support Level
  • TLSA $0.68
  • CLSD $0.90
  • Resistance Level
  • TLSA $0.80
  • CLSD $0.97
  • Average True Range (ATR)
  • TLSA 0.08
  • CLSD 0.05
  • MACD
  • TLSA 0.01
  • CLSD 0.00
  • Stochastic Oscillator
  • TLSA 34.34
  • CLSD 24.29

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

About CLSD Clearside Biomedical Inc.

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

Share on Social Networks: